For research teamsHelp me find a study
Back to all studies
CompletedNCT01914393

Effectiveness of lurasidone in Schizophrenia; Autism; Depression in bipolarity

This study is completed in the United States, in France, in Bulgaria, .... It is testing lurasidone for Schizophrenia; Autism; Depression in bipolarity.

Schizophrenia, Bipolarity, ...DrugFrom 6 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Lurasidone 20, 40, 60, 80 mg, flexibly dosed may be useful for children experiencing schizophrenia.

What would participation involve?

Participants may receive Lurasidone 20, 40, 60, 80 mg, flexibly dosed, attend study visits with the research team. The registry lists locations in Bulgaria, in Colombia, and in France.

Who is it mainly for?

This study appears to be mainly for children with schizophrenia. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: September 30, 2013
Recruitment status
Completed
Enrollment listed in the registry
702
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Bulgaria, ...
Age range
From 6 Years to 17 Years
Official registry ID
NCT01914393
Official title
A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01914393. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Bulgaria · 4 sites
  • MHC - Ruse, EOOD
    Rousse
    Site status: Not listed — confirm with the team
  • UMHAT "Alexandrovska" EAD
    Sofia
    Site status: Not listed — confirm with the team
  • MHAT-Targovishte, AD
    Targovishte
    Site status: Not listed — confirm with the team
  • DCC "Mladost M" - Varna, OOD
    Varna
    Site status: Not listed — confirm with the team
Colombia · 3 sites
  • Centro de Investigaciones y Proyectos en Neurociencias CIPNA
    Barranquilla
    Site status: Not listed — confirm with the team
  • E.S.E. Hospital Mental de Antioquia
    Bello
    Site status: Not listed — confirm with the team
  • Centro de Investigaciones del Sistema Nervioso Limitada - Grupo CISNE Ltda
    Bogotá
    Site status: Not listed — confirm with the team
France · 1 site
  • CHU Nantes - Hôpital Mère-Enfant
    Nantes
    Site status: Not listed — confirm with the team
Hungary · 2 sites
  • Vadaskert Alapitvany a Gyermekek Lelki Egeszsegeert
    Budapest
    Site status: Not listed — confirm with the team
  • Bekes Megyei Pandy Kalman Korhaz
    Gyula
    Site status: Not listed — confirm with the team
Malaysia · 1 site
  • University Malaya Medical Centre
    Kuala Lumpur
    Site status: Not listed — confirm with the team
Mexico · 6 sites
  • Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada S.C.
    Culiacán, Sinaloa
    Site status: Not listed — confirm with the team
  • Dr. Jessica Rosas Escobar
    Durango
    Site status: Not listed — confirm with the team
  • Instituto de Investigaciones Aplicadas a la Neurociencia A.C.
    Durango
    Site status: Not listed — confirm with the team
  • Accelerium S. de R.L. de C.V.
    Monterrey
    Site status: Not listed — confirm with the team
  • Instituto de Informacion de Investigacion en Salud Mental
    Monterrey
    Site status: Not listed — confirm with the team
  • Av Modesto Arreola #917 Ote. Col Centro
    Nuevo León
    Site status: Not listed — confirm with the team
Philippines · 4 sites
  • Alexian Brothers Health and Wellness Center
    Davao City
    Site status: Not listed — confirm with the team
  • West Visayas State University Medical Center
    Iloilo City
    Site status: Not listed — confirm with the team
  • National Center for Mental Health
    Mandaluyong
    Site status: Not listed — confirm with the team
  • Veterans Memorial Medical Center
    Quezon City
    Site status: Not listed — confirm with the team
Poland · 2 sites
  • NZOZ Poradnia Zdrowia Psychicznego
    Kobierzyce
    Site status: Not listed — confirm with the team
  • Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, Oddzial Kliniczmy VI Psychiatrii Mlodziezy
    Torun
    Site status: Not listed — confirm with the team
Puerto Rico · 1 site
  • Centro de Investigacion Clinica Psiquiatrica
    Caguas
    Site status: Not listed — confirm with the team
Romania · 3 sites
  • Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Socola
    Iași
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Urgenta pentru Copii "Louis Turcanu" Timisoara
    Timișoara
    Site status: Not listed — confirm with the team
Russia · 11 sites
  • GUZ Lipetsk Regional psychoneurological Hospital #1
    Lipetsk
    Site status: Not listed — confirm with the team
  • Closed corporation "Scientific Center of Personalized Psychiatry"
    Moscow
    Site status: Not listed — confirm with the team
  • Scientific Center of Personalized Psychiatry
    Moscow
    Site status: Not listed — confirm with the team
  • State Healthcare Institution of Nizhniy Novgordo region "Clinical Psychiatric Hospital #1 of City of Nizhniy Novgorod"
    Nizhny Novgorod
    Site status: Not listed — confirm with the team
  • SHI "City Psychoneurological dispensary #7 (with Hospital)"
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Center of Recovery Treatment "Pediatric Psychiatry" named after S.S. Mnukhin
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Bekhterev Institute
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Regional Clinical Mental Hospital of Saint Sofiya
    Saratov
    Site status: Not listed — confirm with the team
  • FSBSI "Scientific Research Institute of Mental Health"
    Tomsk
    Site status: Not listed — confirm with the team
  • State Healthcare Institution of Yaroslavl Rgion "Yaroslavl Regional clinical Mental Hospital"
    Yaroslavl
    Site status: Not listed — confirm with the team
  • Sverdiovsk Regional Clinical Psychiatric Hospital
    Yekaterinburg
    Site status: Not listed — confirm with the team
South Korea · 4 sites
  • Seoul National University Hospital
    Seoul, Gyeonggi-do
    Site status: Not listed — confirm with the team
  • Chonnam National University Hospital
    Gwangju
    Site status: Not listed — confirm with the team
  • Inha University Hospital
    Incheon
    Site status: Not listed — confirm with the team
  • Chonbuk National University Hospital
    Jeonju
    Site status: Not listed — confirm with the team
Spain · 1 site
  • Hospital Marítimo de Torremolinos
    Torremolinos, Málaga
    Site status: Not listed — confirm with the team
Ukraine · 10 sites
  • RPsH #3 Сhildren Dept SHEI Ivano-Frankivsk SMU
    Ivano-Frankivsk
    Site status: Not listed — confirm with the team
  • SI Institute of Neurology, Psychiatry and Narcology of NAMSU
    Kharkiv
    Site status: Not listed — confirm with the team
  • SI Institute of Children and Adolescents Healthcare of NAMSU
    Kharkiv
    Site status: Not listed — confirm with the team
  • TMA Psychiatry in Kyiv Center of NT & Rehabilitation of Psychotic Conditions
    Kyiv
    Site status: Not listed — confirm with the team
  • CI Lviv Regional Clinical Psychiatric Hospital
    Lviv
    Site status: Not listed — confirm with the team
  • Odesa Regional Psychoneurological Dispensary, Outpatient Dept.
    Odesa
    Site status: Not listed — confirm with the team
  • O.F. Maltcev Poltava RCPsH Children Dept Ukrainian Medical Stomatological Academy
    Poltava
    Site status: Not listed — confirm with the team
  • CI Kherson Regional Psychiatric Hospital of Kherson RC
    Stepanovka
    Site status: Not listed — confirm with the team
  • Ternopil RCCPH Dept of Psychiatry #9 (adolescent)& #8 (pediatric) Ternopil I.Ya. Gorbachevskyi SMU
    Ternopil
    Site status: Not listed — confirm with the team
  • Reg. Psych. Hosp.n.a. O.Yuschenko, Dept. #121 VNMI
    Vinnitsia
    Site status: Not listed — confirm with the team
United States · 35 sites
  • Harmonex Neuroscience Research
    Dothan, Alabama
    Site status: Not listed — confirm with the team
  • Diligent Clinical Trials, Inc
    Downey, California
    Site status: Not listed — confirm with the team
  • University of California San Francisco Medical Center
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center of Orange County
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials - Parent
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc.
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • APG Research, LLC
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Medical Research Group of Central Florida
    Sanford, Florida
    Site status: Not listed — confirm with the team
  • University of South Florida
    St. Petersburg, Florida
    Site status: Not listed — confirm with the team
  • University of South Florida Rothman Center of Neuropychiatry
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Attalla Consultants, LLC
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Psychiatric Associates
    Overland Park, Kansas
    Site status: Not listed — confirm with the team
  • University Of Kentucky
    Lexington, Kentucky
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Kennedy Krieger Institute
    Baltimore, Maryland
    Site status: Not listed — confirm with the team
  • Neurobehavioral medicine Group, LLC
    Bloomfield Hills, Michigan
    Site status: Not listed — confirm with the team
  • St. Charles Psychiatric Associates
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Jersey Shore University Medical Center
    Neptune City, New Jersey
    Site status: Not listed — confirm with the team
  • North Shore/Long Island Jewish PRIME
    Glen Oaks, New York
    Site status: Not listed — confirm with the team
  • Dr. Jeanette Cueva
    Mount Kisco, New York
    Site status: Not listed — confirm with the team
  • Montefiore Medical Center PRIME
    New York, New York
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Richmond Behavioral Associates
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • University of Cincinnati Medical Center
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • University Hospitals Case Medical Center
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • The Ohio State University Nisonger Center
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research, LLC
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Family Psychiatry of The Woodlands, P.A.
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Ericksen Research & Development, LLC
    Clinton, Utah
    Site status: Not listed — confirm with the team
  • University of Virginia
    Charlottesville, Virginia
    Site status: Not listed — confirm with the team
  • Neuroscience, Inc.
    Herndon, Virginia
    Site status: Not listed — confirm with the team
  • Clinical Research Partners, LLC
    Petersburg, Virginia
    Site status: Not listed — confirm with the team
  • Carilion Clinic
    Roanoke, Virginia
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lurasidone 20, 40, 60, 80 mg, flexibly dosed. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 6 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.